Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Splitting Mealtime Insulin for High Fat/Protein Meals in T1DM
NCT04783376Phase 4Completed
- Sponsor
- Sohag University
- Start
- Apr 2021
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin lispro and regular human insulin in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Sohag University. Primary endpoint: Capillary blood glucose levels at 6 hours. Started Apr 2021; status: completed.
02
Drugs
insulin lisproregular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04783376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04783376.